Clinical Research Directory
Browse clinical research sites, groups, and studies.
Therapeutic Effects of Jing Si Herbal Tea for COPD
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Summary
Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung tissue damage. Jing Si herbal tea (JSHT) is known to have anti-inflammatory effects but has not been explored for treating COPD. This study investigated the potential of JSHT as an adjuvant therapy for COPD. This randomized controlled study focused on patients with COPD in the exacerbation and stable phases. The control group received the standard treatment, and the JSHT group received the standard treatment plus JSHT. Both groups underwent HRQL assessments, blood tests, and cellular studies involving five different groups to assess the effect of JSHT on damage-associated molecular patterns (DAMPs) and inflammatory markers.
Official title: Therapeutic Effects of Jing Si Herbal Tea for Chronic Obstructive Pulmonary Disease: A Comprehensive Investigation From Clinical to Basic Research
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2022-01-01
Completion Date
2024-12-31
Last Updated
2024-09-05
Healthy Volunteers
No
Conditions
Interventions
Jing Si herbal tea (JSHT)
JSHT has been approved by the Ministry of Health and Welfare of Taiwan (registration number MOHW-PM-060635).
Placebo
Placebo of JSHT
Locations (1)
Taipei Tzu Chi Hospital
New Taipei City, Xindan, Taiwan